Cowen & Co. analyst Boris Peaker downgrades Macrogenics (NASDAQ:MGNX) from Outperform to Market Perform.
Cowen & Co. Downgrades Macrogenics to Market Perform
Cowen & Co. analyst Boris Peaker downgrades Macrogenics (NASDAQ:MGNX) from Outperform to Market Perform.
Related Posts
Morgan Stanley’s Compliance Efforts Under Spotlight As Federal Regulators Investigate Handling of Wealth Management Clients
Federal regulators, including SEC and OCC, probe Morgan Stanley's client vetting for money laundering. Treasury and Fed consider actions. Focus on client investigations and financial activity monitoring.
Aspen Aerogels Sues Korean Aerogel Supplier And Norwegian Parent Company For Patent Infringement
Patent infringement and unfair trade practices actions filed against Beerenberg in Korea for infringing Aspen's patents on aerogel materials and processes.NORTHBOROUGH, Mass., April 20, 2023 /PRNewswire/ -- Aspen
Analyst Ratings for CARISMA Therapeutics
Within the last quarter, CARISMA Therapeutics (NASDAQ:CARM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…